30-05-11 Clinical outcome after pre-incision Aim Study - - PDF document

30 05 11
SMART_READER_LITE
LIVE PREVIEW

30-05-11 Clinical outcome after pre-incision Aim Study - - PDF document

30-05-11 Clinical outcome after pre-incision Aim Study assessment of aortic atherosclerosis by A-View echocardiography in 5,553 To determine the diagnostic effect of the introduction of elective cardiac surgery patients


slide-1
SLIDE 1

30-­‑05-­‑11 ¡ 1 ¡

A R N O N I E R I C H , W O U T E R J A N S E N K L O M P , L I N D A P E E L E N , G E O R G E B R A N D O N B R A V O B R U I N S M A A R N O U D V A N T H O F F

ISALA CLINICS, ZWOLLE, NETHERLANDS UNIVERSITY MEDICAL CENTER UTRECHT, JULIUS CENTER FOR HEALTH SCIENCES AND PRIMARY CARE, DEPARTMENT OF EPIDEMIOLOGY, UTRECHT, NETHERLANDS

Clinical outcome after pre-incision assessment of aortic atherosclerosis by A-View echocardiography in 5,553 elective cardiac surgery patients

Aim Study

 To determine the diagnostic effect of the introduction of

A-View on clinical outcome

 Question:

 A-View  postoperative reduction in 30 Day Mortality?

 Primary endpoint: 30 day mortality  Secondary endpoint

 clinical neurological event  (CVA = any CT <30 days after surgery)  Combined mortality and CVA

Stroke and Encephalopathy After Cardiac Surgery An Update

Guy M. McKhann, et al. Stroke. 2006;37:562-571

7% ¡ 3% ¡ 30% ¡ 60% ¡ ?? ¡ Death ¡ Stroke ¡ Delirium ¡ Cogni;ve ¡dysfunc;on ¡ Demen;a ¡ Stroke and Encephalopathy After Cardiac Surgery An Update

Guy M. McKhann, et al. Stroke. 2006;37:562-571

0% 2% 4% 6% 8% 10% 12% 50 55 60 65 70 75 80 85

Age

Reeks2 Reeks1

Stroke Death

Etiology Aortic Source

Perioperative Stroke

Magdy Selim. N Engl J Med 2007;356:706-13

Blind spot by TEE

Meta-analysis of the diagnostic accuracy of transesophageal echocardiography for assessment of atherosclerosis in the ascending aorta in patients undergoing cardiac surgery

B Van Zaane, et al. Acta Anaesthesiol Scand 2008; 52: 1179– 1187

Visualization of the Distal Ascending Aorta With A-Mode Transesophageal Echocardiography

  • A. Nierich, et al. Journal of Cardiothoracic and Vascular

Anesthesia, Vol 22, No 5 , 2008: pp 766-773

Diagnostic accuracy of modified transoesophageal echocardiography for pre- incision assessment of aortic atherosclerosis in cardiac surgery patients

B Van Zaane, et al. BJA June 10, 2010

Imaging of the distal ascending aorta using modified transesophageal echocardiography in cardiac surgery

B Van Zaane PhD dissertation 5 nov 2009

Cost-effectiveness analysis of modified transoesophageal echocardiography to assess the distal ascending aorta before incision in cardiac surgery patients.

Nierich, EACTA 2010. Koffijberg et al. Medical Decision Making submited.

slide-2
SLIDE 2

30-­‑05-­‑11 ¡ 2 ¡

Design & methods

 Period Jan 2006- september 2010.

 Follow up till march 2011.

 Observational study of diagnostic effect  Non-randomized comparative intervention study

 No surgical intervention protocol

 Complete Case Analysis

 Patient cohort total: 5553  - A-View: 707  +A-View: 4846

 Analyses (multivariable):

 Dependent: Mortality & Combined 30-day endpoint  Independent: A-View  Multivariate correction for confounding by indication (demographics,

surgery)

Baseline Characteristics of patients with and without monitoring with A-View Operative Characteristics of patients with and without monitoring with A-View

Crude Outcomes Analysis

 Multivariate correction of combined end-point for

patient + operative characteristics of A-View

 Model 0: A-View  Model 1: Euroscore  Patient characteristics  Model 2: Euroscore + operative characteristics  Operative characteristics  CABG, AVR, ARR, AAR  ECC time  Aortic clamp time  Minimal core temperature

30 day mortality

adjusted for patient + operative characteristics of A-View

0,2 0,4 0,6 0,8 1 1,2 1,4 1,6 1,8 2

A-View Euroscore Euroscore + clinical characteristics

OR: 0.96, 95% CI: 0.88 to 1.72 OR: 0.71, 95% CI: 0.43 to 1.18 OR: 0.61, 95% CI: 0.36 to 1.03

slide-3
SLIDE 3

30-­‑05-­‑11 ¡ 3 ¡

combined endpoint (mortality-CVA)

adjusted for patient + operative characteristics of A-View

0,2 0,4 0,6 0,8 1 1,2 1,4 1,6 1,8

A-View Euroscore Euroscore + clinical characteristics

OR: 1.23, 95% CI: 0.88 to 1.72 OR: 0.93, 95% CI: 0.66 to 1.32 OR: 0.85, 95% CI: 0.59 to 1.21

Cause of Mortality 30 day

0% 5% 10% 15% 20% 25% 30% 35% Unknown Cardiac Tamponade CVA Pulmonary Multiple organ failure Infectious Other A-View + A-View -

Conclusions

 Now possible to identify patients at high risk before

surgery or Trans-Aortic Valve Implantation

 Creating awareness by A-View leads to surgical

adaptation

 A-View monitoring tends to reduce mortality by 40%

Current:

  • A-View 3 trial. MRI study embilization after CABG
  • Standard care Isala during Cardiac surgery and TAVI
  • Advanced TEE A-View course by Isala Academy & Patient safety

department

  • Start of new surgical team approach and treatment modalities